Perindopril for Control of Blood Pressure in Patients with Hypertension and Other Cardiovascular Risk Factors: An Open-Label, Observational, Multicentre, General Practice-Based Study

Author： Richard Ian Ogilvie  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.28, Iss.11, 2008-01, pp. : 673-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Telmisartan in Patients with Arterial Hypertension: An Open-Label Observational Study

By Michel M.C.  

Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. : 335-344

Adis International

Access to resources Recommend Favorite

Costs of Eprosartan versus Diuretics for Treatment of Hypertension in a Geriatric Population: An Observational, Open-Label, Multicentre Study

By Gregori Joaquin A. Alvarez  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 617-626

Adis International

Access to resources Recommend Favorite

Dose-Dependent Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice-Based Study

By Tsoukas George  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 1, 2011-02 ,pp. : 45-55

Adis International

Access to resources Recommend Favorite

Pioglitazone Lowers Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus: An Open, Multicentre, Observational Study

By Konrad Thomas   Lübben Georg   Franzen Christine  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 337-340

Adis International

Access to resources Recommend Favorite

Factors Associated with Bleeding in Elderly Hospitalized Patients Treated with Enoxaparin Sodium: A Prospective, Open-Label, Observational Study

By Levin Avi  

Drugs & Aging, Vol. 26, Iss. 1, 2009-01 ,pp. : 77-85

Adis International

Access to resources Recommend Favorite